Chemoradiotherapy Vs chemoradiotherapy with intraluminal brachytherapy is compared for treatment of ca esophagus
Not Applicable
- Conditions
- Health Condition 1: C154- Malignant neoplasm of middle thirdof esophagus
- Registration Number
- CTRI/2019/01/016826
- Lead Sponsor
- IGMC Shimla
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.All histologically proven cases of middle one â?? third of esophageal carcinoma
2.Previously untreated.
3.Lesions not more than 10 cm on barium swallow and endoscopy.
4.Karnofsky Performance status (KPS) of more than 60%.
5.Age of the patients should be 30-70yrs.
Exclusion Criteria
1.Patient not willing to give consent
2.Patient who has already received radiotherapy
3.Patients with distant metastasis.
4.Age >70 years & <30years
5.Deranged KFT (BUN or serum creatinine 2 times above the normal)
6.Deranged LFT (Bilirubin 2 times above the normal limit)
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method